BofA-ML's Favourite Banking Stocks to Ride Modi Optimism
Bank of America Merrill Lynch (BoAML) has increased its target price for some banking stocks by 10 to 45 per cent, on expectations that a strong mandate for the Narendra Modi-led government will help kick-start the investment cycle.
BoAML expects loan growth to rise to 17 per cent by FY16, led by better lending to corporate and infrastructure projects. "A stable government is more likely to facilitate progress on stalled projects and create a more enabling environment for stressed companies to raise equity," says BoAML in a report. It believes the credit cycle to improve which will result in improved asset quality for banks and result in lower slippages for banks in FY15 compared to FY14. As per RBI data, loan growth was 14 per cent in FY14.
Economists at BoAML expect economic growth to recover to 5.4 per cent in FY15 and 6.5 per cent in FY16.
BoAML says in last ten years private banks on an average traded at two times their book value and it could get re-rated to 2.5 to 3 times their book value. In case of public sector banks, the price-to-book multiple could get re-rated to 1.8 to 2.2 times, as compared to last ten years average of 1.5, BoAML adds.
In the private bank segment, its top picks remain ICICI Bank, Axis Bank and Yes Bank whereas in the PSU segment Bank of Baroda, Punjab National Bank and State Bank of India.
For ICICI Bank it has revised the target to Rs 1,850 from earlier target of Rs 1,525, whereas for for Axis Bank and Yes Bank it has revised the target price to Rs 2,250 and Rs 700 respectively compared to Rs 1,825 and Rs 550 given earlier.
Here is the list of revised target price for banks given by BoAML.

-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.